Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Allergy ; 67(5): 609-21, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22339348

RESUMO

BACKGROUND: More than 90% of house dust mite-allergic patients are sensitized to the major Dermatophagoides pteronyssinus allergen, Der p 2. The aim of this study was to develop and characterize an allergy vaccine based on carrier-bound Der p 2 peptides, which should allow reducing IgE- and T-cell-mediated side-effects during specific immunotherapy (SIT). METHODS: Five Der p 2 peptides (P1-P5) were synthesized and analyzed regarding IgE reactivity and allergenic activity. Lymphoproliferative and cytokine responses induced with Der p 2 and Der p 2 peptides were determined in peripheral blood mononuclear cells from mite-allergic patients. Der p 2-specific IgG antibodies induced with carrier-bound Der p 2 peptides in mice and rabbits were tested for their capacity to inhibit IgE binding and basophil activation in allergic patients. RESULTS: Of five overlapping peptides (P1-P5) covering the Der p 2 sequence, two peptides (P2 and P4) were identified, which showed no relevant IgE reactivity, allergenic activity, and induced lower Der p 2-specific T-cell activation than Der p 2. However, when coupled to a carrier, P2 and P4 induced Der p 2-specific IgG antibodies in animals, which inhibited allergic patients' IgE binding to the allergen and allergen-induced basophil activation similar as antibodies induced with Der p 2. CONCLUSIONS: Carrier-bound Der p 2 peptides should allow avoiding IgE-mediated side-effects, and because of their low potential to activate allergen-specific T cells, they may reduce late-phase side-effects during SIT. Further, these peptides may be also useful for prophylactic vaccination.


Assuntos
Alérgenos/imunologia , Anticorpos Bloqueadores/imunologia , Antígenos de Dermatophagoides/imunologia , Proteínas de Artrópodes/imunologia , Basófilos/imunologia , Hipersensibilidade/imunologia , Imunoglobulina G/imunologia , Peptídeos/imunologia , Sequência de Aminoácidos , Animais , Especificidade de Anticorpos/imunologia , Antígenos de Dermatophagoides/química , Proteínas de Artrópodes/química , Basófilos/metabolismo , Citocinas/imunologia , Citocinas/metabolismo , Feminino , Hemocianinas/química , Humanos , Imunoglobulina E/imunologia , Imunoglobulina E/metabolismo , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Ativação Linfocitária/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Peptídeos/química , Diester Fosfórico Hidrolases/metabolismo , Ligação Proteica/imunologia , Pyroglyphidae/imunologia , Pirofosfatases/antagonistas & inibidores , Pirofosfatases/metabolismo , Coelhos , Linfócitos T/imunologia , Linfócitos T/metabolismo , Vacinas Conjugadas/imunologia
2.
Clin Exp Allergy ; 39(11): 1711-20, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19860818

RESUMO

BACKGROUND: KIT tyrosine kinase inhibitors (TKI), such as nilotinib or midostaurin (PKC412), are increasingly used in clinical trials to counteract neoplastic cell growth in patients with aggressive mast cell (MC) disorders. However, these patients suffer not only from MC infiltration and consecutive organ damage but also from MC mediator-related symptoms. METHODS: We examined the effects of three KIT TKI, imatinib, nilotinib, and midostaurin, on IgE-dependent mediator release in normal human blood basophils and cultured cord blood cell-derived MC, and on spontaneous histamine secretion in the MC leukaemia cell line HMC-1 and the basophil cell line KU812. RESULTS: The multi-kinase inhibitor midostaurin that interacts with KIT and protein kinase C was found to counteract anti-IgE-induced mediator release in blood basophils and cultured cord blood cell-derived MC in all samples examined. By contrast, no effects of imatinib or nilotinib on histamine secretion in basophils or MC were found. The effects of midostaurin on histamine release were dose-dependent and occurred at pharmacologic concentrations (IC(50) 10-100 nm). Midostaurin was also found to inhibit the IgE-dependent up-regulation of CD63 on cultured cord blood cell-derived human MC, but did not inhibit IgE-dependent up-regulation of CD63 or CD203c in human blood basophils. CONCLUSION: Midostaurin may be a beneficial drug in aggressive systemic mastocytosis not only because of its growth-inhibitory effects but also because of its additional effects on activation and mediator release in MC and basophils.


Assuntos
Basófilos/metabolismo , Inibidores Enzimáticos/farmacologia , Imunoglobulina E/farmacologia , Mediadores da Inflamação/metabolismo , Mastócitos/metabolismo , Estaurosporina/análogos & derivados , Antígenos CD/biossíntese , Linhagem Celular , Linhagem Celular Tumoral , Inibidores Enzimáticos/uso terapêutico , Humanos , Imunoglobulina E/metabolismo , Mastocitose Sistêmica/tratamento farmacológico , Mastocitose Sistêmica/metabolismo , Diester Fosfórico Hidrolases/biossíntese , Glicoproteínas da Membrana de Plaquetas/biossíntese , Proteínas Proto-Oncogênicas c-kit/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-kit/metabolismo , Pirofosfatases/biossíntese , Estaurosporina/farmacologia , Estaurosporina/uso terapêutico , Tetraspanina 30 , Regulação para Cima/efeitos dos fármacos
3.
Allergy ; 64(3): 398-405, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19120070

RESUMO

BACKGROUND: The association between cigarette smoke exposure and allergic airway disease is a matter for debate. We sought to investigate in an in vitro system whether active smoking reduces the integrity and barrier function of the respiratory epithelium and thus facilitates allergen penetration. METHODS: We cultured the human bronchial epithelial cell line 16HBE14o- in a transwell culture system as a surrogate for the intact respiratory epithelium. The cell monolayer was exposed to standardized cigarette smoke extract (CSE). The extent and effects of trans-epithelial allergen penetration were measured using 125I-labelled purified major respiratory allergens (rBet v 1, rPhl p 5 and rDer p 2) and histamine release experiments. RESULTS: Exposure of cells to concentrations of CSE similar to those found in smokers induced the development of para-cellular gaps and a decrease in trans-epithelial resistance. CSE exposure induced a more than threefold increase in allergen penetration. Increased subepithelial allergen concentrations provoked a substantial augmentation of histamine release from sensitized basophils. CONCLUSIONS: Our results indicate that cigarette smoke is a potent factor capable of reducing the barrier function of the respiratory epithelium for allergens and may contribute to increased allergic inflammation, exacerbation of allergic disease and boosting of IgE memory.


Assuntos
Alérgenos/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , Nicotiana/efeitos adversos , Mucosa Respiratória/metabolismo , Alérgenos/imunologia , Linhagem Celular , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular/imunologia , Citocinas , Citometria de Fluxo , Liberação de Histamina/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Mucosa Respiratória/imunologia , Fumaça
4.
Eur J Clin Invest ; 38(5): 326-35, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18363719

RESUMO

BACKGROUND: Systemic mastocytosis (SM) is a clonal myeloid disorder characterized by abnormal accumulation and growth of mast cells (MC) in internal organs. In most cases, the bone marrow is involved. Expression of CD25 in bone marrow MC, with or without coexpression of CD2, is an important minor SM criterion. So far, most studies have examined CD25-expression on MC by flow cytometry. MATERIALS AND METHODS: We examined the expression of CD25 in MC in patients with SM (n = 25) by immunohistochemistry (IHC) and compared these data with results obtained by flow cytometric assessment of CD25-expression. In addition, we compared CD25-staining results with that obtained with an antibody against CD2. RESULTS: In a majority of all patients (> 80%), CD25 was detectable by both staining techniques. However, in one patient, CD25 was only detectable on MC by IHC, but not by flow cytometry, and in two patients in whom IHC could not be applied because of lack of compact MC infiltrates, flow cytometry revealed aberrant expression of CD25. The antibody against CD2 produced diagnostic staining results in a smaller group of patients (flow cytometry: 65%; IHC: 28% of SM cases) compared to CD25 (> 80%). CONCLUSIONS: CD25-IHC is equally diagnostic and sensitive in SM compared to flow cytometry and thus can be recommended as a diagnostic test. Our data also suggest that the diagnostic value of CD25 exceeds that of CD2, and that optimal assessment of CD25-expression in neoplastic MC in all patients requires the application of both techniques, flow cytometry and IHC.


Assuntos
Antígenos CD/análise , Medula Óssea/patologia , Citometria de Fluxo/métodos , Imuno-Histoquímica , Mastocitose Sistêmica/diagnóstico , Adolescente , Adulto , Idoso , Biomarcadores Tumorais/metabolismo , Medula Óssea/imunologia , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Mastócitos/patologia , Mastocitose Sistêmica/imunologia , Mastocitose Sistêmica/metabolismo , Pessoa de Meia-Idade
5.
Allergy ; 63(6): 695-702, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18325077

RESUMO

BACKGROUND: We have identified a monoclonal anti-human immunoglobulin E (IgE) antibody, which recognizes FcepsilonRI-bound IgE and prevents binding of IgE to FcepsilonRI. In this study, we assessed the binding kinetics and affinity of monoclonal antibody 12 (mAb12) for IgE and investigated whether mAb12 can be used for depletion of IgE and isolation of IgE-bearing cells from peripheral blood. METHODS: Binding kinetics and affinity for IgE were studied using Biacore surface plasmon resonance technique experiments. IgE antibodies were depleted from serum using sepharose-coupled mAb12 and IgE-bearing cells were enriched from heparinized blood samples with mAb12. The extent and biological relevance of IgE depletion were studied by quantitative IgE measurements and basophil histamine release experiments. Specific binding of mAb12 to IgE-bearing cells (basophils, mast cells, IgE-secreting plasma cells) was demonstrated by FACS. RESULTS: Monoclonal antibody 12 shows rapid association (k(a) = 5.46e5/Ms) with IgE, almost no dissociation (k(d) = 8.8e-5/s) and an affinity for IgE (K(D) = 1.61e-10 M), which is as high as that of FcepsilonRI. Immobilized mAb12 could be used to deplete IgE antibodies and isolate IgE-bearing cells from peripheral blood in a single-step procedure. CONCLUSIONS: Monoclonal antibody 12 is a high affinity anti-human IgE antibody, which efficiently removes IgE and IgE-bearing cells from peripheral blood and may thus be used for extracorporeal depletion of IgE and IgE-bearing cells.


Assuntos
Anticorpos Anti-Idiotípicos/imunologia , Anticorpos Monoclonais/imunologia , Afinidade de Anticorpos , Imunoglobulina E/imunologia , Receptores de IgE/imunologia , Rinite Alérgica Sazonal/imunologia , Adulto , Alérgenos/imunologia , Anticorpos Monoclonais/metabolismo , Basófilos/imunologia , Basófilos/metabolismo , Feminino , Liberação de Histamina , Humanos , Imunoglobulina E/sangue , Masculino , Mastócitos/imunologia , Mastócitos/metabolismo , Pessoa de Meia-Idade , Plasmócitos/imunologia , Plasmócitos/metabolismo , Pólen/imunologia , Receptores de IgE/metabolismo
6.
Allergy ; 63(6): 758-67, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18445190

RESUMO

BACKGROUND: The house dust mite (HDM) Dermatophagoides pteronyssinus is a major allergen source eliciting allergic asthma. The aim of the study was to identify new important HDM allergens associated with allergic asthma. METHODS: A cDNA coding for a new mite allergen, designated Der p 21, was isolated using immunoglobulin E (IgE) antibodies from patients with allergic asthma out of a D. pteronyssinus expression cDNA library and expressed in Escherichia coli. RESULTS: Circular dichroism analysis of the purified allergen showed that rDer p 21 (14 726 Da) is one of the few mite allergens with an alpha-helical secondary structure. The protein exhibited high thermal stability and refolding capacity, and, as determined by small angle X-ray scattering, formed a dimer consisting of two flat triangles. rDer p 21 bound high levels of patients' IgE antibodies and showed high allergenic activity in basophil activation experiments. Rabbit anti-Der p 21 IgG antibodies inhibited mite-allergic patients' IgE binding and allowed the ultrastructural localization of the allergen in the midgut (epithelium, lumen and faeces) of D. pteronyssinus by immunogold electron microscopy. Der p 21 revealed sequence homology with group 5 mite allergens, but IgE and IgG reactivity data and cross-inhibition studies identified it as a new mite allergen. CONCLUSIONS: Der p 21 is a new important mite allergen which is liberated into the environment via faecal particles and hence may be associated with allergic asthma.


Assuntos
Alérgenos/química , Alérgenos/imunologia , Antígenos de Dermatophagoides/química , Antígenos de Dermatophagoides/imunologia , Asma/imunologia , Dermatophagoides pteronyssinus/imunologia , Alérgenos/genética , Alérgenos/isolamento & purificação , Sequência de Aminoácidos , Animais , Antígenos de Dermatophagoides/genética , Antígenos de Dermatophagoides/isolamento & purificação , Sequência de Bases , Basófilos/imunologia , Dicroísmo Circular , DNA Complementar , Dermatophagoides pteronyssinus/ultraestrutura , Poeira/imunologia , Células Epiteliais/imunologia , Células Epiteliais/ultraestrutura , Humanos , Imunoglobulina E/imunologia , Intestinos/imunologia , Intestinos/ultraestrutura , Microscopia Imunoeletrônica , Dados de Sequência Molecular
7.
Int J Immunopathol Pharmacol ; 21(4): 797-806, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19144265

RESUMO

The ectoenzyme E-NPP3 (CD203c) has recently been identified as a novel activation-linked cell surface antigen on basophils. In the present study, we examined expression of CD203c on normal mast cells (MC)and bone marrow (bm) MC derived from 85 patients with systemic mastocytosis (SM), including cases with indolent SM (ISM, n=72), SM with associated clonal hematologic non-MC-lineage disease (SM-AHNMD, n=6), aggressive SM (ASM, n=3), and mast cell leukemia (MCL, n=4). Surface expression of CD203c was analyzed by multicolor flow cytometry. In patients with SM, bm MC expressed significantly higher amounts of CD203c compared to normal bm MC (median MFI in controls: 260 versus median MFI in SM: 516, p<0.05). Slightly lower amounts of CD203c were detected on MC in SM-AHNMD and ASM compared to ISM. To demonstrate CD203c expression in MC at the mRNA level, neoplastic MC were highly enriched by cell sorting, and were found to express CD203c mRNA in RT-PCR analysis. Cross-linking of the IgE receptor on MC resulted in a substantial upregulation of CD203c, whereas the KIT-ligand stem cell factor (SCF) showed no significant effects. In conclusion, CD203c is a novel activation-linked surface antigen on MC that is upregulated in response to IgE receptor cross-linking and is overexpressed on neoplastic MC in patients with SM.


Assuntos
Mastócitos/imunologia , Mastocitose/imunologia , Neoplasias/imunologia , Diester Fosfórico Hidrolases/imunologia , Pirofosfatases/imunologia , Receptores de IgE/imunologia , Regulação para Cima , Sequência de Bases , Primers do DNA , Citometria de Fluxo , Humanos , Diester Fosfórico Hidrolases/genética , Pirofosfatases/genética , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa
9.
Curr Cancer Drug Targets ; 12(1): 51-63, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22165967

RESUMO

Heat shock protein 32 (Hsp32), also known as heme oxygenase 1 (HO-1), has recently been identified as a potential target in various hematologic malignancies. We provide evidence that Hsp32 is constitutively expressed in primary leukemic cells in patients with acute myeloid leukemia (AML) and in various AML cell lines (HL60, U937, KG1). Expression of Hsp32 mRNA was demonstrable by qPCR, and expression of the Hsp32 protein by immunocytochemistry and Western blotting. The stem cell-enriched CD34+/CD38+ and CD34+/CD38- fractions of AML cells were found to express Hsp32 mRNA in excess over normal CD34+ progenitor cells. Two Hsp32-targeting drugs, pegylated zinc-protoporphyrin (PEG-ZnPP) and styrene-maleic-acid-copolymer-micelle-encapsulated ZnPP (SMAZnPP), were found to inhibit cytokine-dependent and spontaneous proliferation in all 3 AML cell lines as well as in primary AML cells. Growth inhibitory effects of SMA-ZnPP and PEG-ZnPP were dose-dependent with IC50 values ranging between 1 and 20 µM, and were accompanied by apoptosis as evidenced by light- and electron microscopy, Tunel assay, and caspase-3 activation. Finally, we were able to demonstrate that SMA-ZnPP inhibits cytokine-dependent proliferation of CD34+/CD38+ and CD34+/CD38- AML progenitor cells in vitro in all patients as well as leukemiainitiation of AML stem cells in NOD-SCID IL-2Rγ(-/-) (NSG) mice in vivo. Together, our data suggest that Hsp32 plays an important role as a survival factor in leukemic stem cells and as a potential new target in AML.


Assuntos
ADP-Ribosil Ciclase 1/antagonistas & inibidores , Antígenos CD34 , Inibidores do Crescimento/farmacologia , Heme Oxigenase-1/antagonistas & inibidores , Maleatos/farmacologia , Glicoproteínas de Membrana/antagonistas & inibidores , Metaloporfirinas/farmacologia , Células-Tronco Neoplásicas/efeitos dos fármacos , Polietilenoglicóis/farmacologia , Poliestirenos/farmacologia , Células-Tronco/efeitos dos fármacos , ADP-Ribosil Ciclase 1/biossíntese , ADP-Ribosil Ciclase 1/deficiência , Idoso , Animais , Antígenos CD34/biossíntese , Feminino , Inibidores do Crescimento/uso terapêutico , Células HL-60 , Heme Oxigenase-1/biossíntese , Humanos , Leucemia Mieloide Aguda/tratamento farmacológico , Leucemia Mieloide Aguda/imunologia , Leucemia Mieloide Aguda/metabolismo , Masculino , Maleatos/uso terapêutico , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/deficiência , Metaloporfirinas/uso terapêutico , Camundongos , Camundongos Endogâmicos NOD , Camundongos SCID , Pessoa de Meia-Idade , Células-Tronco Neoplásicas/imunologia , Células-Tronco Neoplásicas/metabolismo , Polietilenoglicóis/uso terapêutico , Poliestirenos/uso terapêutico , Células-Tronco/imunologia , Células-Tronco/metabolismo , Células Tumorais Cultivadas , Células U937
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA